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India is a nation of hypertension declared by ICMR 
and AIIMS. In India 33% of urban population and 25 % 
of rural population suffer from hypertension
[1]
 and 
about ~50 million of US population and worldwide 
25% of population were suffering  with  Hypertension. 
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High Blood pressure is a major cardiovascular risk 
factor
[2-4]
 and contributes significantly to 
cardiovascular mortality.
[5],[6]
 Prospective Studies 
Collaboration has reported that reducing BP can 
substantially decrease cardiovascular risk and stroke 
as well as all cause mortality. Reduction of 5mm of Hg 
in SBP and DBP results in Average Percent Reduction 
of Stroke incidence by 35-40%,
[7]
 Myocardial 
infarction 20-25%, and Heart failure 50%.
[8]
 Among all 
hypertension 90 - 95 % comes under Essential 
Hypertension or primary Hypertension, 10 - 15% 
comes under secondary hypertension. Secondary 
hypertension is curable in initial stages. Essential 
hypertension is a silent killer due to its asymptomatic 
nature and it is manageable and treatable but not 
curable.  
In stage 3 it directly leads to end organ damage 
complications without signs and symptoms. Before 
stage 3 most of the cases relapse in stage 1 to stage 2 
A B S T R A C T  
In worldwide 25% of population is suffering with Hypertension.  As it is an instrumental disease, 
asymptomatic in nature, it was named as Silent killer. The causative factors of Essential hypertension 
were Genetic predisposition and environmental factors but these factors are triggered by stress hence 
it comes under stress related psycho-somatic disorder. In Hypertensive patients, Decrease in 5mm of 
Hg in SBP and DBP results in decrease in cardiovascular risk, stroke which decreases mortality rate 
worldwide. The management aspect of modern medical science remains symptomatic with 
troublesome side effects. The Joint National Committee (JNC 8) guideline advise higher blood pressure 
goals, less use of several types of antihypertensive medications and suggests lifestyle modification 
and relaxation are the best initial therapy. In Ayurveda, Shirodhara is one of the panchakarma 
therapy meant for relaxation and stress reducing procedure mentioned in Dharakalpaas a preventive 
and curative treatment for many stress related disorders. So, Present study is planned as “A 
Comparative clinical evaluation of Shirodhara with Sukhos ̩n̩ajala, Tila tailam and Brahmitailamin the 
management of mild to moderate essential hypertension”was selected. This paper is going to describe 
about conclusion drawn from the study i.e. effect of three types of dhara on Objective parameters 
SBP, DBP, PP, and MAP. 
Key words: Essential Hypertension, Shirodhara, SBP, DBP, PP, MAP. 
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i.e., mild to moderate essential hyperten
population out of 100 people, Only 50
using Antihypertensive drugs out of whic
are maintaining their BP at target goal (
25 people are failed to maintain BP levels
The management aspect of modern me
remains symptomatic with troublesome 
So, compared with previous hypertensio
guidelines, the Joint National Commit
guidelines advise higher blood pressure g
of several types of antihypertensive m
and suggests lifestyle modification and re
the best initial therapy of choice for p
complications there by controlling d
mortality.
[3]
 There is a need of explori
effective remedies from Ayurveda. Shiro
of the panchakarma therapy practised i
1400 years for relaxing the mind and w
various stress related disorders. Prese
planned as “A Comparative clinical e
Shirodhara with Sukhosnajala, Tilata
Brahmi Tailam in the management 
moderate essential hypertension” was s
purpose of this clinical study is to assess 
Shirodhara in primary hypertension. 
effective, the Dravya used for Shirodh
impact on the efficacy. To evaluate this, 
are formed with three Dravyas i.e. Sukho
Tailam and Brahmi Tailam to do 
Comparative assessment is done whethe
technique is important or the Dravyas
Dhara also has effect on results. 
CLINICAL PLAN 
Phase - 1 
Selection of  60 cases of mild to moder
hypertensive patients  after proper exam
criteria are randomly allocated into three 
Group A : Jaladhara 
Group B : Tila Taila Dhara 
Group C : Brahmi Taila Dhara 
Phase - 2 
All the registered patients who ar
hypertensive drugs will be put on placebo
y in the management of mild to moderate 
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ate essential 
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e on Anti-
 for 4 weeks 
to wash out the hyperten
body. Monitoring blood p
Shirodhara average of thre
and standing position, m
maintained for three postu
maintained for each readin
of treatment. 
Phase - 3 
Functional evaluation of th
patients by parameters. 
Objective Parameters 
1. Systolic blood pressure
2. Diastolic blood pressur
3. Mean arterial pressure
4. Pulse pressure 
RESULTS 
Effect of Group - A (
parameters  
In Jaladhara group, for 20
total mean of SBP, DBP, PP
was 153.65, 90.85, 62.80 
After jaladhara the total 
MAP was reduced to 151.9
respectively. But statistical
there is no great difference
of all parameters. After 15
mean of SBP,DBP,PP and
157.00, 90.30 66.70 and 1
than the before treatm
significant. So it was con
some effect on SBP, DBP, P
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Effect of Group - B (Tila Taila Dhara) 
parameters  
In Tila Taila Dhara group, for 20 number
the total mean of SBP, DBP, PP and 
treatment was 154.20, 94.30, 59.90 
respectively. After Tila Taila Dhara the t
SBP, DBP, PP and MAP was reduced to 1
56.40 and 108.75 respectively and statis
significant at 0.01. After 15 days of follow
mean of SBP, DBP, PP and MAP was 1
56.75, 110.37 noted and statistically high
at 0.01 when compared to before treatme
concluded that Tila Taila Dhara decreases
effect was maintained after follow-up.  
Effect of Group - C (Brahmi Taila Dhara
parameters 
In Brahmi Taila Dhara group, for 20 
patients the total mean of SBP, DBP, P
before treatment was 159.60, 99.75, 5
and after Brahmi Taila Dhara the total m
DBP, PP and MAP was reduced to 14
55.60, 105.58 and statistically highly s
0.01. After 15 days of follow up the total m
DBP, PP and MAP was 140.50, 85.20,5
noted and statistically highly significant a
compared to before treatment.  
So it was concluded that Brahmi Taila
markedly prolonged effect on SBP, DBP, 
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Comparison between three groups on MAP 
 
Tables showing results within the groups and between 
the groups; 
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DISCUSSION 
On the basis of this study, it can be concluded that, 
Shirodhara procedure/therapy is recommended not 
only to relieve stress but also used for prevention of 
the disease progression by pacifying the signs. In 
Group A - Jala Dhara, After the course of treatment of 
14 days, SBP reduced up to 3 mm of Hg, DBP reduced 
up to 8 -10 mm of Hg, MAP is also came to normal and 
statistically highly significant at 0.01. No effect was 
noticed for PP. For follow-up after 15 days, the SBP 
and PP levels increased than the readings noted 
before the treatment. DBP and MAP also increased as 
noted earlier in before treatment. Thus concluded 
that jaladhara effectively reduces peripheral 
resistance as it decrease diastolic blood pressure up 
to 10 mm of Hg.  
When compared to Group - B Tila Taila Dhara no 
greater mean difference was noted between two 
groups. Hence it is proved that irrespective of drug 
used in Dhara, the Shirodhara procedure itself has 
clinical efficacy in reducing symptoms. As observed 
from the results, Jaladhara only effective immediately 
after treatment and it has no long lasting effect on 
objective parameters while observing the follow-up 
readings. 
In Group B - Tila Taila Dhara, After the course of 
treatment 14 days, SBP reduced up to 8 mm of Hg, 
DBP reduced up to 8 - 12 mm of Hg, MAP and PP was 
also came to normal and statistically highly significant 
at 0.01. For follow-up after 15 days, the SBP, DBP, 
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MAP and PP levels mildly increased than the readings 
noted after the treatment but not increased as noted 
earlier in before treatment. And statistically highly 
significant at 0.01. Thus concluded that Tila Taila 
Dhara is better than the Jala Dhara for long effect on 
Hypertension. But mild increase of 2 - 4 mm of Hg was 
noted in both SBP and DBP in Follow-up. 
In Group C - Brahmi  Taila Dhara, After the course of 
treatment 14 days, SBP reduced up to 15-18 mm of 
Hg, DBP reduced up to 12-15 mm of Hg, MAP and PP 
was also came to normal and statistically highly 
significant at 0.01. For follow-up after 15 days, the 
SBP, DBP, MAP and PP levels mildly increased than the 
readings noted after the treatment but not increased 
as noted earlier in before treatment. And statistically 
highly significant at 0.01.  
During the follow up study, it was found that there 
was rise in systolic and diastolic pressure suggesting 
the palliative nature of the treatment. But this rise in 
blood pressure was early in Jaladhara and Tila Taila 
Dhara treated separate groups as compared to the 
Brahmi Taila Dhara. It suggests that effect of Brahmi 
Taila Dhara remains for longer period. Hence 
comparatively, Brahmi Taila Dhara is better than the 
Tila Taila Dhara and Jaladhara. 
Jaladhara helped in reducing both systolic and 
diastolic pressure, while Tila Taila Dhara reduced both 
systolic and diastolic pressure in a more pronounced 
way, where as Brahmi Taila Dhara showed speedy 
improvement than the individual groups. 
Furthermore, it was also found during treatment that 
some of the patients improved to such an extent that 
they had either stopped the modern antihypertensive 
drug completely or minimized its dose, suggesting 
that the Shirodhara also potentiate the therapeutic 
efficacy of the modern drug, thus being helpful in 
avoiding the side effect of modern drug too. On the 
basis of this study, a better line of management can 
be offered to the patients, if stress-relieving 





Blood pressure depends on several factors mainly on 
cardiac output and total peripheral resistance. Cardiac 
output depends on blood volume. Persistent increase 
in blood volume may cause persistent blood pressure. 
Blood volume is maintained by stressed volume in the 
arterial side and unstressed volume in the venous 
side. Along with genetic pre-disposition some 
environmental factors especially like chronic 
psychosocial stress may cause arterial and peripheral 
vessels constriction causing increased stress volume 
and unstressed volume respectively. In Ayurveda, 
Shirodhara is a peculiar Panchakarma procedure used 
to relieve the mental stress by relaxing the mind and 
dilatation of peripheral vessels there by helps in 
maintaining the blood pressure. In this study all the 
three groups irrespective of drug Shirodhara 
procedure itself played major role in bringing the 
objective parameters to normal but the Shirodhara 
procedure with Dravya like Brahmi showed wonderful 
results in maintaining the blood pressure. 
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